loadpatents
name:-0.035653114318848
name:-0.014057159423828
name:-0.0037710666656494
TANIGAWARA; Yusuke Patent Filings

TANIGAWARA; Yusuke

Patent Applications and Registrations

Patent applications and USPTO patent grants for TANIGAWARA; Yusuke.The latest application filed is for "marker for assessing sensitivity to combination anticancer drug".

Company Profile
3.15.16
  • TANIGAWARA; Yusuke - Shinjuku-ku JP
  • Tanigawara; Yusuke - Kawasaki JP
  • TANIGAWARA; Yusuke - Kawasaki-shi JP
  • Tanigawara; Yusuke - Tokyo JP
  • Tanigawara; Yusuke - Kanagawa JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Marker For Assessing Sensitivity To Combination Anticancer Drug
App 20220082564 - SUGIMOTO; Shinji ;   et al.
2022-03-17
Marker For Determining Sensitivity Of Irinotecan-containing Anti-cancer Agent Therapy
App 20210088522 - SUGIMOTO; Shinji ;   et al.
2021-03-25
Combined Anticancer Agent Sensitivity Determination Marker
App 20200191772 - SUGIMOTO; Shinji ;   et al.
2020-06-18
Combined anticancer drug sensitivity-determining marker
Grant 10,481,160 - Tanigawara , et al. Nov
2019-11-19
Method for determining sensitivity to fluorouracil in a subject having colorectal cancer
Grant 10,309,957 - Tanigawara , et al.
2019-06-04
Marker For Determination Of Sensitivity To Anticancer Agent
App 20180038848 - TANIGAWARA; Yusuke ;   et al.
2018-02-08
Marker for determination of sensitivity to anticancer agent
Grant 9,797,884 - Tanigawara , et al. October 24, 2
2017-10-24
Combined Anticancer Drug Sensitivity-determining Marker
App 20170299597 - TANIGAWARA; Yusuke ;   et al.
2017-10-19
Anti-cancer Agent Sensitivity-determining Marker
App 20170248578 - TANIGAWARA; Yusuke ;   et al.
2017-08-31
Combined anticancer drug sensitivity-determining marker
Grant 9,733,256 - Tanigawara , et al. August 15, 2
2017-08-15
Method for determining sensitivity to an anticancer agent
Grant 9,459,254 - Tanigawara , et al. October 4, 2
2016-10-04
Method for determination of sensitivity to anti-cancer agent
Grant 9,089,540 - Tanigawara , et al. July 28, 2
2015-07-28
Combined Anticancer Drug Sensitivity-determining Marker
App 20150038522 - Tanigawara; Yusuke ;   et al.
2015-02-05
Marker for determination of sensitivity to anti-cancer agent
Grant 8,945,929 - Tanigawara , et al. February 3, 2
2015-02-03
Anticancer agent sensitivity-determining marker
Grant 8,809,362 - Tanigawara , et al. August 19, 2
2014-08-19
Method for determination of sensitivity to anti-cancer agent
Grant 8,765,713 - Tanigawara , et al. July 1, 2
2014-07-01
Marker For Determination Of Sensitivity To Anticancer Agent
App 20140107068 - Tanigawara; Yusuke ;   et al.
2014-04-17
Anticancer Agent Sensitivity-determining Marker
App 20120220618 - Tanigawara; Yusuke ;   et al.
2012-08-30
Method For Determining Sensitivity To An Anticancer Agent
App 20120220613 - Tanigawara; Yusuke ;   et al.
2012-08-30
Method For Determination Of Sensitivity To Anti-cancer Agent
App 20120214831 - Tanigawara; Yusuke ;   et al.
2012-08-23
Marker For Determination Of Sensitivity To Anti-cancer Agent
App 20110003842 - Tanigawara; Yusuke ;   et al.
2011-01-06
Method For Determination Of Sensitivity To Anti-cancer Agent
App 20100323034 - Tanigawara; Yusuke ;   et al.
2010-12-23
Gene Markers and Utilization of the Same
App 20090162868 - Tanigawara; Yusuke ;   et al.
2009-06-25
Gene Marker and Use Thereof
App 20090053695 - Tanigawara; Yusuke ;   et al.
2009-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed